What is the address of Buysse Medical Supplies and Services?

The registered office of Buysse Medical Supplies and Services is located at Werkstraat 29, 9000 Gent.

Is Buysse Medical Supplies and Services still active?

Yes. According to the CBE (29 October 2026) Buysse Medical Supplies and Services is active, legal situation “Normale toestand”, started on 26 November 1997.

Is Buysse Medical Supplies and Services registered on Peppol?

Yes, Buysse Medical Supplies and Services is registered on the Peppol network with ID 0208:0461922809.

What is the enterprise number of Buysse Medical Supplies and Services?

The enterprise number of Buysse Medical Supplies and Services is BE0461922809.

When was Buysse Medical Supplies and Services founded?

Buysse Medical Supplies and Services was founded on 26 November 1997.

Who are the directors of Buysse Medical Supplies and Services?

According to the 2025 annual accounts, the directors of Buysse Medical Supplies and Services are: Group Maria Louise, Peter Buysse.

Is Buysse Medical Supplies and Services a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 November 1997; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Buysse Medical Supplies and Services make in 2025?

Buysse Medical Supplies and Services posted a profit after taxes of € 19,743 in financial year 2025.

What is the revenue of Buysse Medical Supplies and Services?

As a small company, Buysse Medical Supplies and Services is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 64,109.

Buysse Medical Supplies and Services (Private Limited)

Q: What does Buysse Medical Supplies and Services do?

Buysse Medical Supplies and Services is registered with the CBE as active in: Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden. Private Limited, started on 26 November 1997, 1 establishment.

Dossier Buysse Medical Supplies and Services, printed on 29 October 2026 from databakkes.be/en/0461922809/buysse-medical-supplies-and-services. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Figures corrected NBB

Corrected annual account filed for 2023.

Financials

Financial year 2025

Buysse Medical Supplies and Services from Gent, company number BE0461922809, closed financial year 2025 with a result of € 19,743 after tax. For that financial year Buysse Medical Supplies and Services recorded a gross margin of € 64,109 and equity of € 149,437. Compared with financial year 2024, the result moved from € -25,955 to € 19,743. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 12, 2026.

What it is worth Growing

€ 149,437

▲ 15% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 19,743

▲ still € 25,955 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 44,811

▲ € 38,353 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 87,464.

People and assets in 2025

Vehicles and equipment

€ 6,954

▼ 24% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 126,155

▲ 14% vs 2024

€ 13,380 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 50,194

▼ 39% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 24,544

▼ 3% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	-	-	€ 465,419 Revenue 2024: € 465,419 First fiscal year in the series	-
Gross margin	€ 23,734 Gross margin 2022: € 23,734 First fiscal year in the series	€ 62,903 Gross margin 2023: € 62,903 ▲ 165% vs 2022 (€ 23,734) Favourable step	€ 138 Gross margin 2024: € 138 ▼ € 62,765 vs 2023 (€ 62,903) Unfavourable step	€ 64,109 Gross margin 2025: € 64,109 ▲ € 63,971 vs 2024 (€ 138) Favourable step	▲ € 63,971
Profit after taxes	€ -202 Profit after taxes 2022: € -202 First fiscal year in the series	€ 30,540 Profit after taxes 2023: € 30,540 ▲ € 30,742 vs 2022 (€ -202) Favourable step	€ -25,955 Profit after taxes 2024: € -25,955 ▼ € 56,496 vs 2023 (€ 30,540) Unfavourable step	€ 19,743 Profit after taxes 2025: € 19,743 ▲ € 45,698 vs 2024 (€ -25,955) Favourable step	▲ € 45,698
Equity	€ 252,845 Equity 2022: € 252,845 First fiscal year in the series	€ 217,043 Equity 2023: € 217,043 ▼ 14% vs 2022 (€ 252,845) Unfavourable step	€ 129,694 Equity 2024: € 129,694 ▼ 40% vs 2023 (€ 217,043) Unfavourable step	€ 149,437 Equity 2025: € 149,437 ▲ 15% vs 2024 (€ 129,694) Favourable step	▲ 15%
Total debts	€ 326,254 Total debts 2022: € 326,254 First fiscal year in the series	€ 298,830 Total debts 2023: € 298,830 ▼ 8% vs 2022 (€ 326,254) Favourable step	€ 280,536 Total debts 2024: € 280,536 ▼ 6% vs 2023 (€ 298,830) Favourable step	€ 216,923 Total debts 2025: € 216,923 ▼ 23% vs 2024 (€ 280,536) Favourable step	▼ 23%
Cash	€ 0 Cash 2022: € 0 First fiscal year in the series	€ 9,018 Cash 2023: € 9,018 Unchanged (€ 0) Favourable step	€ 6,458 Cash 2024: € 6,458 ▼ 28% vs 2023 (€ 9,018) Unfavourable step	€ 44,811 Cash 2025: € 44,811 ▲ € 38,353 vs 2024 (€ 6,458) Favourable step	▲ € 38,353
Land & buildings	€ 169,037 Land & buildings 2022: € 169,037 First fiscal year in the series	€ 171,141 Land & buildings 2023: € 171,141 ▲ 1% vs 2022 (€ 169,037) Unchanged	€ 165,978 Land & buildings 2024: € 165,978 ▼ 3% vs 2023 (€ 171,141) Unchanged	€ 148,874 Land & buildings 2025: € 148,874 ▼ 10% vs 2024 (€ 165,978) Unchanged	▼ 10%
Retained profit	€ 190,871 Retained profit 2022: € 190,871 First fiscal year in the series	€ 155,070 Retained profit 2023: € 155,070 ▼ 19% vs 2022 (€ 190,871) Unfavourable step	€ 67,721 Retained profit 2024: € 67,721 ▼ 56% vs 2023 (€ 155,070) Unfavourable step	€ 87,464 Retained profit 2025: € 87,464 ▲ 29% vs 2024 (€ 67,721) Favourable step	▲ 29%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 66,342 Dividend 2023: € 66,342 Unchanged (€ 0) Unchanged	€ 61,394 Dividend 2024: € 61,394 ▼ 7% vs 2023 (€ 66,342) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 61,394) Unchanged	▼ 100%
Bank debt	€ 134,399 Bank debt 2022: € 134,399 First fiscal year in the series	€ 126,047 Bank debt 2023: € 126,047 ▼ 6% vs 2022 (€ 134,399) Favourable step	€ 111,113 Bank debt 2024: € 111,113 ▼ 12% vs 2023 (€ 126,047) Favourable step	€ 126,155 Bank debt 2025: € 126,155 ▲ 14% vs 2024 (€ 111,113) Unfavourable step	▲ 14%
Balance sheet total	€ 579,099 Balance sheet total 2022: € 579,099 First fiscal year in the series	€ 515,873 Balance sheet total 2023: € 515,873 ▼ 11% vs 2022 (€ 579,099) Unchanged	€ 410,231 Balance sheet total 2024: € 410,231 ▼ 20% vs 2023 (€ 515,873) Unchanged	€ 366,360 Balance sheet total 2025: € 366,360 ▼ 11% vs 2024 (€ 410,231) Unchanged	▼ 11%

Key figures of Buysse Medical Supplies and Services, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Buysse Medical Supplies and Services?

What happened at Buysse Medical Supplies and Services in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 12, 2026 New annual accounts for financial year 2025: profit of € 19,743. Source: NBB ↗
2025 Peter Buysse became a director. NBB
2009 Group Maria Louise became a director. NBB
Nov 28, 1997 New establishment in Gent. KBO
Nov 26, 1997 Start of the company according to the CBE. KBO

In short

From € 202 loss in 2022 to € 19,743 profit in 2025.

Paid € 11,785 in corporate taxes since 2022.

Best year ever: 2023, with € 30,540 profit.

Paid out € 127,735 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Group Maria Louise Peter Buysse

Buysse Medical Supplies and Services

Kompas

vereniging zonder winstoogmerk Labeur

Behind Buysse Medical Supplies and Services are Group Maria Louise and Peter Buysse. Peter Buysse is also behind Kompas and vereniging zonder winstoogmerk Labeur.

Directors

According to the 2025 annual accounts

Group Maria Louise

Director

since 2009

Peter Buysse

Director

Also active at: Kompas, vereniging zonder winstoogmerk Labeur

since 2025

Establishments

Establishment units

Physical locations of this company

Registered office

Werkstraat 29

9000 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0461.922.809

VAT number

BE 0461.922.809

Registered office

Werkstraat 29, 9000 Gent

Names & denominations

Buysse Medical Supplies and Services · BMS²

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

26 November 1997

Peppol

Active · Active since 1 Mar 2024

Activities · NACE

Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden

Vervaardiging van elektrische apparaten voor de geneeskunde, de tandheelkunde en de veeartsenijkunde

View on CBE Public ↗ Annual accounts (NBB) ↗